Scholars Central

Short communicationPublished 26 Nov 2020

Pharmaceutical innovations and medical knowledge on diabetes for T2DM treatments: A short communication

Authors: Chakraborty N

Journal of Diabetes & Clinical Practice

Volume 3 · Issue 5 · Pages 01–02

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pathogenesis and therapeutics of type 2 diabetes are currently too refractory to be easily managed in the clinics. Medical knowledge and therapeutic options for T2DM treatments are still of great medical significance. We welcome therapeutics of both cutting-edge and traditional for anti-diabetic treatments in future.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Diabetes & Clinical Practice.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes & Clinical Practice
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Chakraborty N”